Mass spectrometry imaging in oncology drug discovery
RJA Goodwin, J Bunch, DF McGinnity - Advances in cancer research, 2017 - Elsevier
Over the last decade mass spectrometry imaging (MSI) has been integrated in to many
areas of drug discovery and development. It can have significant impact in oncology drug …
areas of drug discovery and development. It can have significant impact in oncology drug …
[HTML][HTML] Cholesterolomics: an update
Cholesterolomics can be regarded as the identification and quantification of cholesterol, its
precursors post squalene, and metabolites of cholesterol and of its precursors, in a …
precursors post squalene, and metabolites of cholesterol and of its precursors, in a …
[HTML][HTML] Getting to the heart of intracellular glucocorticoid regeneration: 11β-HSD1 in the myocardium
GA Gray, CI White, RFP Castellan… - Journal of …, 2017 - jme.bioscientifica.com
Corticosteroids influence the development and function of the heart and its response to
injury and pressure overload via actions on glucocorticoid (GR) and mineralocorticoid (MR) …
injury and pressure overload via actions on glucocorticoid (GR) and mineralocorticoid (MR) …
A facile supramolecular approach to fabricate multifunctional upconversion nanoparticles as a versatile platform for drug loading, in vivo delivery and tumor imaging
Multifunctional upconversion nanoparticles (UCNPs) that can be implemented in theranostic
applications are particularly attractive scaffolds for precise drug delivery. However, most of …
applications are particularly attractive scaffolds for precise drug delivery. However, most of …
Assessing the potential of metal-assisted imaging mass spectrometry in cancer research
M Dufresne, NH Patterson, N Lauzon… - Advances in Cancer …, 2017 - Elsevier
In the last decade, imaging mass spectrometry (IMS) has been the primary tool for
biomolecular imaging. While it is possible to map a wide range of biomolecules using matrix …
biomolecular imaging. While it is possible to map a wide range of biomolecules using matrix …
[HTML][HTML] Sterolomics: State of the art, developments, limitations and challenges
WJ Griffiths, Y Wang - Biochimica et Biophysica Acta (BBA)-Molecular and …, 2017 - Elsevier
Sterolomics can be thought of as the quantitative determination of the entire complement of
molecules based on the cyclopentanoperhydrophenanthrene skeleton in a system. Mass …
molecules based on the cyclopentanoperhydrophenanthrene skeleton in a system. Mass …
[PDF][PDF] Стабильные карбокатионы как масс-спектрометрические метки для детекции биомолекул
АП Топольян - Ин-т биоорган. химии им. ММ Шемякина и ЮА …, 2017 - ibch.ru
Масс-спектрометрия (МС) в настоящее время служит мощным методом анализа и
исследования веществ. Развитие методологии, инструментальной базы и способов …
исследования веществ. Развитие методологии, инструментальной базы и способов …
Introduction and Overview of Lipidomic Strategies
WJ Griffiths, Y Wang - Lipidomics, 2017 - Springer
While analysis of the genome or proteome can be predictive of the fate of an organism, its
metabolome is informative of the outcome of events on an organism. The metabolome can …
metabolome is informative of the outcome of events on an organism. The metabolome can …
[PDF][PDF] QUANTIFICATION OF 11B-HYDROXYSTEROID DEHYDROGENASE 1 KINETICS AND PHARMACODYNAMIC EFFECTS OF INHIBITORS IN BRAIN USING …
R Andrew - 2017 - cyberleninka.org
ABSTRACT 11β-Hydroxysteroid dehydrogenase 1 (11β-HSD1; EC 1.1. 1.146) generates
active glucocorticoid hormones. Small molecule inhibitors have been developed to target …
active glucocorticoid hormones. Small molecule inhibitors have been developed to target …
[图书][B] Mass spectrometry methods for profiling xenobiotic distribution in biofluids and whole tissues
JG Swales - 2017 - search.proquest.com
Historically, studies of drug biodistribution are traditionally carried out in the later stages of
pre-clinical pharmaceutical research and development (R&D) using radio-labelled …
pre-clinical pharmaceutical research and development (R&D) using radio-labelled …